Multilevel Intervention to Support Tailored and Responsive HIV Pre-Exposure Prophylaxis Care in Rural North Carolina: Protocol for a Randomized Controlled Trial

被引:0
作者
Rutstein, Sarah E. [1 ]
Ferguson, Ella [2 ]
Mansour, Odai [1 ]
Brown, Nicole [2 ]
Stocks, Jacob B. [3 ]
Washington, Anja [2 ]
Mobley, Victoria [4 ]
Dowler, Shannon [4 ]
Edwards, Jessie [5 ]
Hightow-Weidman, Lisa B. [3 ]
Hurt, Christopher B. [1 ]
Pence, Brian [1 ]
Muessig, Kathryn E. [3 ]
机构
[1] Univ North Carolina, Dept Med, 130 Mason Farm Rd, Chapel Hill, NC 27514 USA
[2] Univ North Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA
[3] Florida State Univ, Inst Digital Hlth & Innovat, Coll Nursing, Tallahassee, FL USA
[4] North Carolina Div Publ Hlth, Dept Hlth & Human Serv, Raleigh, NC USA
[5] Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
来源
JMIR RESEARCH PROTOCOLS | 2025年 / 14卷
基金
美国国家卫生研究院;
关键词
pre-exposure prophylaxis navigation; PrEP navigation; digital health app; mobile health; mHealth; telehealth; public health; sexually transmitted infection; HIV prevention; mobile phone; UNITED-STATES; HEALTH; ADHERENCE; ACCEPTABILITY; IMPLEMENTATION; VALIDATION; PREVENTION; COMMUNITY; HIV/STI; SEX;
D O I
10.2196/68085
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: While access to pre-exposure prophylaxis (PrEP) is an important tool for reducing HIV incidence in the United States, disparities in uptake by race, sex, socioeconomic status, and geography persist. In 2018, the US South accounted for more than half of all new HIV diagnoses but only one-third of PrEP users. PrEP use in North Carolina (NC) similarly lags, with uptake being the lowest among young, sexual and gender minority populations, who account for nearly two-thirds of the state's incident infections.The PrEP-to-need ratio, ametricofPrEPequity that measuresPrEPuptakerelativetonewHIVdiagnoses,highlights disparities in PrEP uptake among specific demographic groups such as women and Black, Hispanic, and Southern people, indicating that these groups are underserved relative to their epidemic need. Despite behavioral risk overlap of incident sexually transmitted infections (STIs) and HIV, in NC, PrEP is only offered at a few primarily urban health department-affiliated STI clinics. The lack of robust health care infrastructure in these areas presents challenges for HIV prevention services. Objective: This protocol describes a randomized controlled trial of a multilevel PrEP intervention recruiting from rural and periurban STI clinics. Methods: This trial aims to enroll up to 336 participants and randomly assign them 1:1 to either the intervention or control group. The intervention consists of access to a digital health app, linkage to a remote PrEP navigator, and the option of referral to telehealth-based PrEPservices. Persons randomly assigned to the control condition will receiveanenhanced standard ofcare, including access to a limited version of the digital health app. All participants will be followed up on quarterly for at least 3 months. The primary outcome is the initiation of PrEP within 3 months of an index STI clinic visit; secondary outcomes evaluate PrEP care engagement and adherence, incident HIV and bacterial STI infections, PrEP stigma, and cost-effectiveness. Binary outcome analyses will estimate the proportion of participants achieving an event (eg, PrEP uptake) in each arm and a probability difference and the corresponding 95% CI to compare the intervention versus control arm at each time point. Continuous end points will use nonparametric Wilcoxon rank sum tests comparing the intervention and control groups. Results: Enrollment opened on August 31, 2023, at 15 health departments in NC and subsequently expanded to 21 facilities in 20 counties by July 2024. Completion of the enrollment and data collection phases is expected by May 2025. Results will be published thereafter. Conclusions:This study directly addresses multiple barriers to PrEP use in rural and periurban areas of the Southeastern United States and can inform policy and programming that seek to expand PrEP access and promote use in underserved communities.
引用
收藏
页数:20
相关论文
共 89 条
  • [1] Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy
    Anderson, Peter L.
    Liu, Albert Y.
    Castillo-Mancilla, Jose R.
    Gardner, Edward M.
    Seifert, Sharon M.
    McHugh, Cricket
    Wagner, Theresa
    Campbell, Kayla
    Morrow, Mary
    Ibrahim, Mustafa
    Buchbinder, Susan
    Bushman, Lane R.
    Kiser, Jennifer J.
    MaWhinney, Samantha
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [2] [Anonymous], Occupational Employment and Wages in Tucson - May 2017
  • [3] [Anonymous], Fast facts: HIV in the US by age
  • [4] [Anonymous], 2021, Understanding the current state of vehicle automation
  • [5] [Anonymous], DEF ROL AUTH CONTR
  • [6] [Anonymous], 2021, NC ending HIV:a plan to end HIV together, community-by-community, hand-in-hand
  • [7] [Anonymous], 2023, 2022 North Carolina STD surveillance report. Table 2. Newly diagnosed HIV rates among adults and adolescents in North Carolina by county of diagnosis, year of diagnosis, and rank order, 2020-2022
  • [8] [Anonymous], 2023, Core indicators for monitoring the ending the HIV epidemic initiative (preliminary data): national HIV surveillance system data reported through June 2023
  • [9] and preexposure prophylaxis (PrEP) data reported through March 2023. HIV surveillance data tables 2023
  • [10] 4(3). Table 3a. Number of persons prescribed PrEP, number of persons with PrEP indications, and PrEP coverage during January 2019 through March 2023, among persons aged >= 16 Years, by selected characteristics-United States (preliminary).